Key result
A multidisciplinary, holistic management approach is key to optimizing prognosis in elderly patients with heart failure who present with multiple comorbidities and pharmacologic challenges.
Why the study?
Heart failure is rapidly increasing in prevalence among the elderly, who have historically been unrepresented in clinical HF trials and present with complex comorbidities and pharmacologic challenges.
Elderly patients with heart failure require a multidisciplinary, holistic management approach due to multiple comorbidities and pharmacologic challenges.
May support holistic multidisciplinary care in elderly HF with comorbidities; leaves open need for dedicated RCTs before practice change.
Heart failure (HF) in the elderly, besides being a leading cause of mortality and morbidity, is rapidly increasing in prevalence with patients aged 65 and older accounting for more than 75% of heart failure hospitalizations. Elderly patients have historically been unrepresented in clinical HF trials and often present with multiple comorbidities, including frailty, depression, nutritional, functional and cognitive impairments. Additionally, pharmacologic challenges such as adherence to therapy, polypharmacy, altered drug pharmacokinetics and/or renal derangements make them less likely to receive guideline-directed medical therapies for HF. Recognition of these various interrelated domains is key and should prompt a multidisciplinary, holistic management approach so as to optimize prognosis in this vulnerable subset of the population.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2019) conducted a review in Heart failure. A multidisciplinary, holistic management approach is key to optimizing prognosis in elderly patients with heart failure who present with multiple comorbidities and pharmacologic challenges.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: